+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Aspergillosis Drug"

Aspergillosis Drugs - Global Strategic Business Report - Product Thumbnail Image

Aspergillosis Drugs - Global Strategic Business Report

  • Report
  • March 2025
  • 373 Pages
  • Global
From
Aspergillosis Treatment Market Report 2025 - Product Thumbnail Image

Aspergillosis Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
Aspergillosis - Pipeline Insight, 2024 - Product Thumbnail Image

Aspergillosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Invasive Aspergillosis - Pipeline Insight, 2024 - Product Thumbnail Image

Invasive Aspergillosis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Allergic Bronchopulmonary Aspergillosis - Pipeline Insight, 2024 - Product Thumbnail Image

Allergic Bronchopulmonary Aspergillosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
From
From
From
From
Invasive Aspergillosis- Epidemiology Forecast to 2032 - Product Thumbnail Image

Invasive Aspergillosis- Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Aspergillosis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Aspergillosis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
From
From
  • 19 Results (Page 1 of 1)
Loading Indicator

Aspergillosis is a type of fungal infection caused by the Aspergillus fungus. It can affect the lungs, sinuses, and other organs. Treatment for aspergillosis typically involves antifungal medications. The Aspergillosis Drug market is a subset of the larger Infectious Diseases Drugs market, which includes drugs used to treat a variety of bacterial, viral, and fungal infections. Aspergillosis drugs are used to treat a variety of forms of the infection, including allergic bronchopulmonary aspergillosis, chronic pulmonary aspergillosis, and invasive aspergillosis. These drugs are typically administered orally or intravenously. Some companies in the Aspergillosis Drug market include Merck & Co., Pfizer, GlaxoSmithKline, AstraZeneca, and Novartis. Show Less Read more